WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Small cell lung cancers (SCLCs) have high mutational burden but are relatively unresponsive to immune checkpoint blockade (ICB). Using SCLC models, we demonstrate that inhibition of WEE1, a G2/M checkpoint regulator induced by DNA damage, activates the STING-TBK1-IRF3 pathway, which increases type I...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Hirokazu, Caeser, Rebecca, Chavan, Shweta S., Zhan, Yingqian A., Chow, Andrew, Manoj, Parvathy, Uddin, Fathema, Kitai, Hidenori, Qu, Rui, Hayatt, Omar, Shah, Nisargbhai S., Villalonga, Álvaro Quintanal, Allaj, Viola, Nguyen, Evelyn M., Chan, Joseph, Michel, Adam O., Mukae, Hiroshi, de Stanchina, Elisa, Rudin, Charles M., Sen, Triparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449677/
https://www.ncbi.nlm.nih.gov/pubmed/35584676
http://dx.doi.org/10.1016/j.celrep.2022.110814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449677/
https://www.ncbi.nlm.nih.gov/pubmed/35584676
http://dx.doi.org/10.1016/j.celrep.2022.110814

Ejemplares similares